We apply our deep understanding of both markets and the science and business of drug development to create effective corporate communications strategies and deliver results. Trophic’s offerings cover all aspects of strategic communications for pharmaceutical and biotech companies including positioning, industry visibility and perception, public and media relations, investor relations and senior counsel.
The key to good public relations lies in identifying the unique traits and goals of each company and building a strategy that emphasizes and cultivates these elements. Through the development of a targeted messaging strategy, we want to support your company in solidifying its position and sharing its own story in the industry. Our public relations services include:
Corporate Positioning & messaging development
Interview coordination & preparation
Social media strategy & support
Conference and Scientific meeting support
Event planning, i.e., scientific symposia, webinars, KOL day, etc.
Navigating and managing investor relations is a critical element to each company regardless of size or industry. At Trophic, we build our investor relations strategy based on research and one-on-one discussions with the financial community to ensure the best outcome for our clients. Our investor relations services include:
Financial communications, i.e quarterly and annual reports, conference call scripts, etc.
Run-up to IPO
Corporate presentation training
Roadshow planning and onsite support
Investor and analyst days
Financial conference support
From corporate websites to comprehensive Q&As, we can offer your firm a range of materials to support you in your messaging and strategy. Our materials services include:
Website creation and updates
Logo and brand development
Corporate presentation development and updates
Media and investor backgrounders
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.